Initial Follow Up Results from the REP 301 Trial: Safety and Efficacy of REP 2139-Ca and Pegylated Interferon Alpha-2a in Caucasian Patients with Chronic HBV / HDV Co-infection

被引：0
|
作者：
Bazinet, Michel [1 ]
Pantea, Victor [2 ]
Cebotarescu, Valentin [2 ]
Cojuhari, Lilia [3 ]
Jimbei, Paulina [3 ]
Albrecht, Jeffrey [4 ]
Schmid, Peter [4 ]
Krawczyk, Adalbert [5 ]
Karimzadeh, Hadi [6 ]
Roggendorf, Michael [6 ]
Valliant, Andrew [1 ]
机构：
[1] Replicor Inc, Montreal, PQ, Canada
[2] N Testemitanu State Univ Med & Pharm, Dept Infect Dis, Kishinev, Moldova
[3] Toma Ciorba Infect Clin Hospita, Kishinev, Moldova
[4] Natl Genet Inst, Los Angeles, CA USA
[5] Univ Klinikum Essen, Inst Virol, Essen, Germany
[6] Tech Univ Munich, Inst Virol, Munich, Germany
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1848
引用
收藏
页码：912A / 912A
页数：1
相关论文
共 38 条
  • [31] Safety and efficacy of an indigenous recombinant interferon-alpha-2b in patients with chronic myelogenous leukaemia: Results of a multicentre trial from India
    Kumar, L
    Gangadharan, VP
    Rao, DR
    Saikia, T
    Shah, S
    Malhotra, H
    Bapsy, PP
    Singh, K
    Rao, R
    NATIONAL MEDICAL JOURNAL OF INDIA, 2005, 18 (02): : 66 - 70
  • [32] Viusid in combination with interferon alpha-2b and ribavirin in patients with chronic hepatitis C.: Efficacy and safety results from a ramdomized controlled trial
    Gomez, E. Vilar
    Gra, B.
    Soler, E. Arus
    Domech, C. Ruenes
    Betancourt, Y.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S144 - S144
  • [33] Safety and efficacy of anti-pre-S1 domain monoclonal antibody (HH-003) treatment in patients with co-infection of chronic hepatitis B virus (HBV) and hepatitis D virus (HDV): a single center, open-label, phase 2 trial
    Wang, Xinrui
    Chi, Xiumei
    Zhang, Yingyu
    Gu, Yumei
    Xiao, Long
    Qi, Yonghe
    Zou, Liangfeng
    Wen, Jiaying
    Zhang, Yin
    Chen, Pan
    Lei, Cong
    Ye, Bin
    Sui, Jianhua
    Li, Wenhui
    Niu, Junqi
    JOURNAL OF HEPATOLOGY, 2023, 78 : S117 - S117
  • [34] Safety and efficacy of an indigenous recombinant interferon-alpha-2b in patients with chronic myelogenous leukaemia: Results of a multicentre trial from India (vol 18, pg 66, 2005)
    Shah, S
    Malhotra, H
    NATIONAL MEDICAL JOURNAL OF INDIA, 2005, 18 (03): : 130 - 130
  • [35] EFFICACY AND SAFETY OF siRNA JNJ-73763989, CAPSID ASSEMBLY MODULATOR- E (CAM-E) JNJ - 56136379, AND NUCLEOS(T) IDE ANALOGS ( NA) WITH PEGYLATED INTERFERON ALPHA-2a (PEGIFN-α2a) ADDED IN IMMUNE - TOLERANT PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION: INTERIM RESULTS FROM THE PHASE 2 REEF- IT STUDY
    Kennedy, Patrick T.
    Fung, Scott K.
    Buti, Maria
    Yilmaz, Gurdal
    Chuang, Wan Long
    Asselah, Tarik
    Kurosaki, Masayuki
    Jezorwski, John
    Verbinnen, Thierry
    Kakuda, Thomas N.
    Lenz, Oliver
    Guinard-Azadian, Carine
    Biermer, Michal
    HEPATOLOGY, 2023, 78 : S568 - S570
  • [36] The safety and efficacy of hepalatide (L47) treatment combined with pegylated interferon-alpha 2a in patients with chronic hepatitis B: the preliminary data from a double-blind, RCT phase II trial
    Fu, Junliang
    Mao, Qing
    Jin, Qinglong
    Cheng, Hui
    Cheng, Yongqian
    Tang, Xiaolu
    Liu, Hongli
    Wang, Fu-Sheng
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1166 - S1167
  • [37] Pegylated interferon alpha 2b plus ribavirin is effective in patients with chronic hepatitis C virus infection and normal liver enzymes: Preliminary results from a prospective, randomized, controlled, multi-center trial.
    Flamm, SL
    Cahan, J
    Goldman, J
    Nelligan, G
    Chua, D
    Shapiro, B
    Bawani, M
    Yapp, R
    Jurkovic, E
    Manka, D
    HEPATOLOGY, 2002, 36 (04) : 293A - 293A
  • [38] EFFICACY AND SAFETY OF siRNA JNJ-73763989, CAPSID ASSEMBLY MODULATOR JNJ-56136379, NUCLEOS(T)IDE ANALOG (NA), AND PEGYLATED INTERFERON ALPHA-2a (PEGIFN-α2a) FOR TREATMENT OF CHRONIC HEPATITIS B (CHB): WEEK 24 RESULTS FROM THE PHASE 2 PENGUIN STUDY
    Gane, Edward John
    Janczewska, Ewa
    Takehara, Tetsuo
    Chuang, Wan-Long
    Peng, Cheng-Yuan
    Hlebowicz, Maria
    Asahina, Yasuhiro
    Chang, Ting-Tsung
    Kalmeijer, Ronald
    Jezorwski, John
    Lenz, Oliver
    Kakuda, Thomas N.
    Verbinnen, Thierry
    Pehlivanov, Nonko
    Anastasiou, Zacharias
    Biermer, Michael
    HEPATOLOGY, 2023, 77 (05) : E147 - E148
1234